Home / IT & Technology / Global AI in Cancer Diagnostics.
Global AI in Cancer Diagnostics Market - Market Research Report

Global AI in Cancer Diagnostics Market

Published Date:Aug 2025
Industry: IT & Technology
Format: PDF
Page: 200
Forecast Period: 2025-2033
Historical Range: 2020-2024
Request Sample Enquiry Before Buying Speak to Analyst

Global AI in Cancer Diagnostics Market Segmentation, By Technology (Machine Learning (ML) {Supervised Learning, Unsupervised Learning, Deep Learning}, Natural Language Processing (NLP), Computer Vision), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancers), By Diagnostic Tool (Radiology Imaging, Pathology, Genomics & Biomarker Analysis, Endoscopy), By End User (Hospitals & Diagnostic Centers, Research Institutes, Pharmaceutical Companies)- Industry Trends and Forecast to 2033

 

Global AI in Cancer Diagnostics Market size was valued at USD 287.6 million in 2024 and is expected to grow at a CAGR of 23.4% during the forecast period of 2025 to 2033.

 

Global AI in Cancer Diagnostics Market Overview

Artificial Intelligence (AI) in most cancers diagnostics is remodeling the manner cancers are detected, analyzed, and managed. Leveraging system learning, deep learning, and picture popularity technologies, AI structures can unexpectedly and correctly examine scientific imaging, pathology slides, and genomic records to perceive cancerous patterns. This hurries up diagnosis, reduces human error, and permits early detection, enhancing affected person outcomes. AI additionally performs a essential function in predictive analytics and customized remedy planning. As most cancers instances upward thrust globally and healthcare structures are seeking for green diagnostic tools, AI-powered solutions are gaining.

 

Global AI in Cancer Diagnostics Market Scope

Factors

Description

Years Considered

·         Historical Period: 2020-2023

·         Base Year: 2024

·         Forecast Period: 2025-2033

Segments

·         By Technology: Machine Learning (ML) {Supervised Learning, Unsupervised Learning, Deep Learning}, Natural Language Processing (NLP), Computer Vision

·         By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancers

·         By Diagnostic Tool: Radiology Imaging, Pathology, Genomics & Biomarker Analysis, Endoscopy

·         By End User: Hospitals & Diagnostic Centers, Research Institutes, Pharmaceutical Companies

Countries Catered

North America

·         United States

·         Canada

·         Mexico

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

Key Companies

·         IBM Watson Health

·         Google Health (DeepMind)

·         Microsoft (InnerEye)

·         Siemens Healthineers

·         GE Healthcare

·         PathAI

·         Tempus Labs

·         Flatiron Health

·         Hologic, Inc.

·         Butterfly Network, Inc.

Market Trends

·         Growing Demand for Personalized Medicine

·         Integration with Radiology and Pathology

 


Global AI in Cancer Diagnostics Market Dynamics

The global AI in cancer diagnostics market is being driven by a convergence of technological advancements, increasing cancer occurrence rates, and growing demand for early and accurate diagnostic solutions. One of the number one drivers is the growing adoption of AI-powered diagnostic equipment through hospitals, study institutions, and diagnostic laboratories to improve diagnostic accuracy, shorten turnaround time, and enhance affected person outcomes. AI systems, particularly the ones that use deep gaining knowledge of and photo analysis, are proving in particularly powerful in detecting diffuse styles in radiology and pathology pictures, which can be frequently overlooked by human eyes. The marketplace is witnessing key traits which include the combination of AI with telepathology, cloud-primarily based totally diagnostics, and next-generation sequencing (NGS) for real-time and remote cancer diagnostics. Additionally, collaborations among AI startups and healthcare carriers are accelerating the commercialization of progressive diagnostic platforms.

 

Opportunities abound in growing areas in which healthcare infrastructure is expanding, and virtual fitness adoption is growing. There's additionally scope for AI packages in uncommon and complicated cancer types, in which conventional diagnostics face limitations. However, restraints that include excessive preliminary implementation costs, regulatory hurdles, and information privacy worries pose demanding situations to wider adoption. Moreover, AI algorithms require large and varied datasets for training, which might not usually be comfortably available, particularly in underdeveloped healthcare markets. Additionally, skepticism amongst clinical specialists concerning AI's reliability and the shortage of standardization in AI fashions, in addition mission its integration into medical workflows.

 

Global AI in Cancer Diagnostics Market Segment Analysis

The global AI in most cancers diagnostics marketplace is segmented throughout 4 key dimensions: technology, cancer type, diagnostic tool, and give up consumer every gambling a vital function in shaping the adoption and effect of AI inside oncology diagnostics. By Technology, the marketplace is divided into Machine Learning (ML), Natural Language Processing (NLP), and Computer Vision. Within ML, supervised mastering is the maximum broadly used because of its reliability in classifying and predicting most cancers kinds primarily based totally on categorized datasets. Unsupervised mastering is gaining traction for its cap potential to locate hidden styles with out pre-categorized facts, beneficial in uncommon most cancers detection. Deep mastering, a subset of ML, is an increasing number of utilized in radiology and pathology for picture recognition, imparting advanced accuracy in tumour detection. NLP is being leveraged to extract vital statistics from scientific notes and studies papers, assisting evidence-primarily based totally diagnostics. Computer Vision permits machines to interpret scientific snap shots including X-rays, MRIs, and pathology slides, automating and accelerating most cancers detection.

 

By Cancer Type, the AI diagnostic marketplace covers essential cancers, including breast cancer, lung cancer, prostate cancer, colorectal cancer, and blood cancers like leukemia and lymphoma. Breast and lung cancers dominate the phase because of their excessive international occurrence and the extent of picture-primarily based totally diagnostics, making them perfect applicants for AI integration. AI is increasingly being applied to improve early detection, staging, and treatment planning for those cancer kinds. By Diagnostic Tool, AI is incorporated into radiology imaging, pathology, genomics & biomarker analysis, and endoscopy. Radiology imaging remains the main application, with AI algorithms notably enhancing accuracy in detecting tumors and metastases. In pathology, AI assists in digitizing and studying biopsy samples, even as in genomics, it aids in deciphering large genomic data for biomarker identification. AI-pushed endoscopy gear is enhancing visualization and anomaly detection at some point of minimally invasive procedures. By End User, hospitals & diagnostic facilities shape the biggest consumer base, pushed through quicker and greater accurate diagnostic processes. Research institutes are also key adopters, the usage of AI to discover new diagnostic methodologies and drug discovery avenues.

 

Global AI in Cancer Diagnostics Market Regional Analysis

The global AI in most cancers diagnostics marketplace famous huge nearby variation, with North America main due to sturdy investments in AI healthcare technologies, sturdy R&D infrastructure, and the presence of key gamers inclusive of IBM Watson Health and Tempus. The United States money owed for the biggest share, pushed through excessive most cancers prevalence, superior imaging systems, and supportive regulatory frameworks from the FDA. Europe follows closely, with global places like Germany and the UK actively integrating AI into public healthcare systems, supported thru tasks similar to the European Cancer Imaging Initiative. The Asia-Pacific vicinity is witnessing rapid growth, specifically in China, Japan, and India, as a result of developing maximum cancers cases, improving healthcare infrastructure, and government investments in AI and precision medicine. Meanwhile, Latin America and the Middle East & Africa are rising markets, wherein growing recognition and virtual fitness reforms are predicted to progressively decorate AI adoption in oncology diagnostics.

 

Global AI in Cancer Diagnostics Market Key Players

·         IBM Watson Health

·         Google Health (DeepMind)

·         Microsoft (InnerEye)

·         Siemens Healthineers

·         GE Healthcare

·         PathAI

·         Tempus Labs

·         Flatiron Health

·         Hologic, Inc.

·         Butterfly Network, Inc.

 

Recent Developments

In December 2024, Sheba Medical Center’s ARC Innovation partnered with Roche to integrate AI algorithms into Roche’s navify® digital pathology platform for non-small cell lung cancer (NSCLC). This joint initiative aims to streamline molecular marker detection and enhance diagnostic precision and speed.

 

In May 2024, South Korea’s Lunit acquired Volpara Health Technologies for approximately KRW 264.7 billion (~USD 191 million). This enhances its breast cancer detection AI suite and expands data resources for autonomous screening models, with ambitions to roll out in developing regions..

 

Research Methodology

At Foreclaro Global Research, our research methodology is firmly rooted in a comprehensive and systematic approach to market research. We leverage a blend of reliable public and proprietary data sources, including industry reports, government publications, company filings, trade journals, investor presentations, and credible online databases. Our analysts critically evaluate and triangulate information to ensure accuracy, consistency, and depth of insights. We follow a top-down and bottom-up data modelling framework to estimate market sizes and forecasts, supplemented by competitive benchmarking and trend analysis. Each research output is tailored to client needs, backed by transparent data validation practices, and continuously refined to reflect dynamic market conditions.

Table of Contents

Chapter 1.  Introduction

1.1.  Report Description

1.2.  Key Market Segments

1.3.  Regulatory Scenario

1.4.  Executive Summary

Chapter 2.  Research Methodology

2.1.  Secondary Research

2.2.  Primary Research

2.3.  Secondary Analyst Tools and Models

Chapter 3.  Market Dynamics

3.1.  Market driver analysis

3.1.1.  Increasing global cancer burden fuels demand for faster and more accurate diagnostic tools

3.1.2.  Enhanced image recognition, pattern detection, and machine learning capabilities

3.2.  Market restraint analysis

3.2.1.  Data Privacy and Regulatory Concerns

3.3.  Market Opportunity

3.3.1.  Advanced neural networks enable detailed tissue-level analysis for cancer detection.

3.4.  Market Challenges

3.4.1.  Cybersecurity Risks

Chapter 4.  Market Variables and Outlook

4.1.  SWOT Analysis

4.1.1.  Strengths

4.1.2.  Weaknesses

4.1.3.  Opportunities

4.1.4.  Threats

4.2.  PESTEL Analysis

4.2.1.  Political Landscape

4.2.2.   Economic Landscape

4.2.3.  Social Landscape

4.2.4.  Technological Landscape

4.2.5.  Environmental Landscape

4.2.6.  Legal Landscape

4.3.  Porter’s Five Forces Analysis

4.3.1.  Bargaining Power of Suppliers

4.3.2.  Bargaining Power of Buyers

4.3.3.  Threat of Substitute

4.3.4.  Threat of New Entrant

4.3.5.  Competitive Rivalry

4.4.  Value Chain Analysis

4.5.  Covid Impact Analysis

Chapter 5.  AI in Cancer Diagnostics Market: Technology Estimates & Trend Analysis

5.1.  AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

5.2.  Incremental Growth Analysis and Infographic Presentation

5.3.  Machine Learning (ML)

5.3.1.  Supervised Learning

5.3.2.  Unsupervised Learning

5.3.3.  Deep Learning

5.4.  Natural Language Processing (NLP)

5.5.  Computer Vision

Chapter 6.  AI in Cancer Diagnostics Market: Cancer Type Estimates & Trend Analysis

6.1.  AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

6.2.  Incremental Growth Analysis and Infographic Presentation

6.3.  Breast Cancer

6.4.  Lung Cancer

6.5.  Prostate Cancer

6.6.  Colorectal Cancer

6.7.  Blood Cancers

Chapter 7.  AI in Cancer Diagnostics Market: Diagnostic Tool Estimates & Trend Analysis

7.1.  AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

7.2.  Incremental Growth Analysis and Infographic Presentation

7.3.  Radiology Imaging

7.4.  Pathology

7.5.  Genomics & Biomarker Analysis

7.6.  Endoscopy

Chapter 8.  AI in Cancer Diagnostics Market: End Users Estimates & Trend Analysis

8.1.  AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

8.2.  Incremental Growth Analysis and Infographic Presentation

8.3.  Hospitals & Diagnostic Centers

8.4.  Research Institutes

8.5.  Pharmaceutical Companies

Chapter 9.  AI in Cancer Diagnostics Market: Regional Estimates & Trend Analysis

9.1.  AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

9.2.  Incremental Growth Analysis and Infographic Presentation

9.3.  North America

9.4.  Europe

9.5.  Asia Pacific

9.6.  Middle East & Africa

9.7.  Latin America

Chapter 10.      AI in Cancer Diagnostics Market: Country Estimates & Trend Analysis

10.1. AI in Cancer Diagnostics Market value share and forecast, (2020 to 2033)

10.2. Incremental Growth Analysis and Infographic Presentation

10.3. United States

10.4. Canada

10.5. Mexico

10.6. United Kingdom

10.7. France

10.8. Germany

10.9. Italy

10.10. Spain

10.11. China

10.12. India

10.13. Japan

10.14. South Korea

10.15. Australia

10.16. Brazil

10.17. Argentina

10.18. Saudi Arabia

10.19. South Africa

Chapter 11.      Competitive Landscape

11.1. Company Market Share Analysis

11.2. Vendor Landscape

11.3. Competition Dashboard

Chapter 12.      Company Profiles

12.1. IBM Watson Health

12.1.1. Company Overview

12.1.2. Financial Details

12.1.3. Product Analysis

12.1.4. Recent Developments

12.2. Google Health (DeepMind)

12.2.1. Company Overview

12.2.2. Financial Details

12.2.3. Product Analysis

12.2.4. Recent Developments

12.3. Microsoft (InnerEye)

12.3.1. Company Overview

12.3.2. Financial Details

12.3.3. Product Analysis

12.3.4. Recent Developments

12.4. Siemens Healthineers

12.4.1. Company Overview

12.4.2. Financial Details

12.4.3. Product Analysis

12.4.4. Recent Developments

12.5. GE Healthcare

12.5.1. Company Overview

12.5.2. Financial Details

12.5.3. Product Analysis

12.5.4. Recent Developments

12.6. PathAI

12.6.1. Company Overview

12.6.2. Financial Details

12.6.3. Product Analysis

12.6.4. Recent Developments

12.7. Tempus Labs

12.7.1. Company Overview

12.7.2. Financial Details

12.7.3. Product Analysis

12.7.4. Recent Developments

12.8. Flatiron Health

12.8.1. Company Overview

12.8.2. Financial Details

12.8.3. Product Analysis

12.8.4. Recent Developments

12.9. Hologic, Inc.

12.9.1. Company Overview

12.9.2. Financial Details

12.9.3. Product Analysis

12.9.4. Recent Developments

12.10. Butterfly Network, Inc.

12.10.1.            Company Overview

12.10.2.            Financial Details

12.10.3.            Product Analysis

12.10.4.            Recent Developments

Segmentation

AI in Cancer Diagnostics Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)

Machine Learning (ML)

·         Supervised Learning

·         Unsupervised Learning

·         Deep Learning

Natural Language Processing (NLP)

Computer Vision

 

AI in Cancer Diagnostics Market, Cancer Type Outlook (Revenue - USD Million, 2020 - 2033)

Breast Cancer

Lung Cancer

Prostate Cancer

Colorectal Cancer

Blood Cancers

 

AI in Cancer Diagnostics Market, Diagnostic Tool Outlook (Revenue - USD Million, 2020 - 2033)

Radiology Imaging

Pathology

Genomics & Biomarker Analysis

Endoscopy

 

AI in Cancer Diagnostics Market, End User Outlook (Revenue - USD Million, 2020 - 2033)

Hospitals & Diagnostic Centers

Research Institutes

Pharmaceutical Companies

 

AI in Cancer Diagnostics Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Methodology

Review our research methodology and quality standards for details about source selection, validation, forecasting, and review.

At Foreclaro Global Research, our research methodology is built to deliver clear, data-backed intelligence that supports confident decision-making. By combining rigorous secondary research, primary validations, and advanced forecasting models, we produce insights that are not only reliable but also strategically relevant for our clients.

 

1. Defining the Research Framework

Every study begins with a clear understanding of our client’s goals. We establish the market scope, define critical variables, and build a research framework tailored to the specific project. This upfront clarity ensures that our findings are sharply aligned with the strategic questions being addressed.

 

2. Robust Data Collection

Our analysts extract high-integrity data from a broad mix of credible sources including government databases, annual reports, regulatory filings, trade publications, scientific journals, and trusted industry portals. This secondary research is then supported with targeted primary inputs through interviews with key industry stakeholders—such as executives, subject matter experts, and channel partners—to capture real-world insights and contextual depth.

 

3. Advanced Forecasting and Modeling

To estimate market size and growth, we employ a hybrid of top-down and bottom-up modeling techniques. Our analysts apply proven forecasting models using historical data trends, economic indicators, technology adoption rates, and demand patterns. Sensitivity analysis and scenario modeling (base, optimistic, conservative) are incorporated to account for market volatility and uncertainty.

 

4. Data Triangulation and Validation

Accuracy is non-negotiable. We cross-validate every data point by triangulating it across three dimensions: source credibility, numerical consistency, and contextual alignment. This ensures our insights are not just statistically correct but strategically dependable. Discrepancies are resolved using subject expertise and multi-perspective reviews to deliver a balanced, unbiased analysis.

 

5. Quality Assurance and Final Review

Before delivery, each report undergoes a stringent quality assurance process. Our research output is reviewed for structure, clarity, consistency, and compliance with global standards. The final deliverable is tailored for decision-makers, whether it's a comprehensive industry report, data dashboard, or strategic presentation.

 

Why Our Methodology Works

What sets us apart is our adaptive data architecture and our commitment to analytical clarity. Every study is built with flexibility to accommodate dynamic markets, while our team blends quantitative rigor with domain-specific expertise. This allows us to deliver research that goes beyond information, we deliver intelligence that leads to action.

Choose License Type

Get A FREE Sample

The free sample includes data points such as market estimates, growth rate, size of the largest region and segment of the market.

Send me a Free Sample

Related Reports